Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Concert Pharmaceuticals Inc (CNCE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Concert Pharm's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Concert Pharm historical data, for real-time data please try another search
8.370 +0.000    +0.00%
03/03 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 8.350 - 8.550
Concert Pharm 8.370 +0.000 +0.00%

CNCE Recent Sentiments

 
This page contains information on users’ sentiments for the Concert Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 02, 2023 Lilia Litvin   8.375 Mar 24, 2023 @ 8.370 -0.06%
Jan 23, 2023 דורון גביש   8.290 Feb 17, 2023 @ 8.380 +1.09%
Jan 19, 2023 Kenan Dumlupınar   8.290 Feb 10, 2023 @ 8.330 +0.48%
Jan 19, 2023 Raúl Ignacio...   8.270 Feb 10, 2023 @ 8.330 +0.73%
Oct 31, 2022 현석 오   6.050 Nov 28, 2022 @ 5.080 -16.03%
Sep 16, 2022 현석 오   6.395 Oct 07, 2022 @ 6.100 -4.61%
Sep 02, 2022 원호 박   6.880 Sep 23, 2022 @ 6.110 -11.19%
Aug 16, 2022 Hojung Kim   6.890 Sep 09, 2022 @ 6.580 -4.50%
Aug 09, 2022 주헌 이   7.090 Sep 02, 2022 @ 6.950 -1.97%
Aug 01, 2022 Andrea Masciadri   5.805 Aug 26, 2022 @ 6.800 +17.14%
Jul 29, 2022 Raúl Ignacio...   5.480 Aug 19, 2022 @ 6.840 +24.82%
Jul 28, 2022 동윤 김   4.965 Aug 19, 2022 @ 6.840 +37.76%
Jul 28, 2022 동윤 김   4.965 Aug 19, 2022 @ 6.840 +37.76%
Jul 05, 2022 Hernan Fernandez   4.590 Jul 29, 2022 @ 5.600 +22.00%
Jun 29, 2022 Raúl Ignacio...   4.570 Jul 22, 2022 @ 4.480 -1.97%
Jun 10, 2022 Varinder Kumar   4.755 Jul 01, 2022 @ 4.270 -10.20%
Jun 07, 2022 Hernan Fernandez   4.950 Jul 01, 2022 @ 4.270 -13.74%
Jun 03, 2022 Erhard Muschaweck   4.580 Jun 06, 2022 @ 4.600 +0.44%
Jun 02, 2022 Cruzeiro dos Santos   4.530 Jun 06, 2022 @ 4.600 -1.55%
Jun 02, 2022 샘 구   4.430 Jun 24, 2022 @ 4.310 -2.71%
Jun 01, 2022 재구 이   5.305 Jun 24, 2022 @ 4.310 -18.76%
May 31, 2022 Yumi Lee   6.030 Jun 24, 2022 @ 4.310 -28.52%
May 31, 2022 Albert Estrada...   6.050 Jun 24, 2022 @ 4.310 -28.76%
May 31, 2022   6.173 Jun 24, 2022 @ 4.310 -30.18%
May 27, 2022 Raúl Ignacio...   6.340 Jun 17, 2022 @ 4.100 -35.33%
May 27, 2022 사랑 산소   5.470 Jun 17, 2022 @ 4.100 -25.05%
May 18, 2022 Daniel Alqassab   4.838 Jun 10, 2022 @ 4.650 -3.89%
Mar 16, 2022 Albert Estrada...   2.918 Apr 08, 2022 @ 3.340 +14.46%
Feb 11, 2022 Albert Estrada...   3.290 Mar 04, 2022 @ 2.880 -12.46%
Nov 09, 2021 Bekzod Yusupov   3.870 Nov 15, 2021 @ 4.020 +3.88%
Nov 05, 2021 فهد الشراري   3.620 Nov 26, 2021 @ 3.630 +0.28%
Nov 04, 2021 jimmy karlsson   4.170 Nov 26, 2021 @ 3.630 -12.95%
Nov 04, 2021 Rami ALmehmadi   4.250 Nov 26, 2021 @ 3.630 +14.59%
Oct 20, 2021 Ashraf Elgendy   2.750 Nov 12, 2021 @ 4.005 +45.64%
Jun 25, 2021 Robbert Kuipers   4.470 Jul 16, 2021 @ 3.490 -21.92%
Jun 25, 2021 Robbert Kuipers   4.470 Jun 25, 2021 @ 4.470 0.00%
Jun 25, 2021 Robbert Kuipers   4.470 Jun 25, 2021 @ 4.470 0.00%
May 12, 2021 Tzvetan Petiov   3.820 May 17, 2021 @ 4.040 +5.76%
Apr 15, 2021 병진 소   4.710 May 07, 2021 @ 4.010 -14.86%
Apr 08, 2021 Bernard Zimermann   4.590 Apr 12, 2021 @ 4.500 -1.96%
Apr 08, 2021 евгений абрамов   4.600 Apr 30, 2021 @ 4.150 -9.78%
Apr 08, 2021 Ashraf Elgendy   4.550 Apr 30, 2021 @ 4.150 -8.79%
Apr 07, 2021 호선 김   5.040 Apr 12, 2021 @ 4.500 -10.71%
Mar 26, 2021 Roland Chung   4.800 Apr 16, 2021 @ 4.410 -8.12%
Mar 26, 2021 jorge luis chaves...   4.790 Apr 16, 2021 @ 4.410 -7.93%
Mar 25, 2021 lillpoddan poddis   5.120 Apr 16, 2021 @ 4.410 -13.87%
Mar 24, 2021 Μακης Βαν   5.440 Apr 16, 2021 @ 4.410 -18.93%
Mar 15, 2021 Bernard Zimermann   6.250 Mar 22, 2021 @ 6.080 -2.72%
Mar 15, 2021 Bernard Zimermann   6.250 Mar 22, 2021 @ 6.080 -2.72%
Mar 11, 2021 Thomas Madura   6.320 Apr 02, 2021 @ 5.240 -17.09%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CNCE Comments

Write your thoughts about Concert Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Michael Boname
Michael Boname Nov 16, 2021 12:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I dont think Ive ever seen a stock with such a strong buy rating that noone is buying.
Nehal Ahmed
Nehal Ahmed Feb 17, 2021 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's wrong with this stock!!!! ;>
Nehal Ahmed
Nehal Ahmed Feb 17, 2021 9:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's wrong with with this stock !!!! 😡
Anand Guru
Anand Guru Feb 01, 2021 3:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Quick buy call on tanzanian Royalty share. Target 40 percentage today
Job Losm
Job Losm Feb 01, 2021 2:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going back to 9 dollar soon
Gianni Latini
Gianni Latini Feb 01, 2021 2:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jaguar Health merger?
Andrew Hill
Andrew Hill Feb 01, 2021 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
http://mus.acrofan.com/article_sub3.php?number=414417&lang=
Jobir Avezov
Jobir Avezov Feb 01, 2021 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Okay thanks mate
Jobir Avezov
Jobir Avezov Feb 01, 2021 8:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is sharply going down?
gerardo Galarza
gerardo Galarza Feb 01, 2021 8:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't know, it's interesting. i will buy
gerardo Galarza
gerardo Galarza Feb 01, 2021 8:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't know, it's interesting. i will buy it?
Jobir Avezov
Jobir Avezov Feb 01, 2021 8:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
gerardo Galarza It was even 5$in premarket I will buy too waiting for dipper
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email